Text and Data Mining valid from 2018-12-03
Received: 15 July 2018
Accepted: 16 October 2018
First Online: 3 December 2018
: K.J.M. and New York University hold a patent (US 9241950, status: issued 26 January 2016) on the use of miR-33 inhibitors to treat inflammation. All other authors have no competing interests.